Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Bringing Kashmir’s lakes back to life 25 min · 23 Sep 2026 · The Documentary Podcast

Soup 56 min · 23 Sep 2026 · Three Bean Salad

AFL Record Editor Ash Browne | Grand Final edition on sale now! (23.09.26) 2 min · 23 Sep 2026 · Whateley

NPR News: 09-22-2026 8PM EDT 4 min · 23 Sep 2026 · NPR News Now

Send Me To Sleep | Aristotle 44 min · 23 Sep 2026 · Send Me To Sleep

Finding the balance between offence & defence | The Art of Coaching with Ken Hinkley! (23.09.26) 5 min · 23 Sep 2026 · Whateley

Report any issue

Source

Recorded13 Dec 2022

Publisherc.answersincme.com ↗

Handlerec:766098

Show notes

Please visit answersincme.com/WZE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses strategies for optimizing immunotherapy in advanced basal cell carcinoma (BCC). Upon completion of this activity, participants should be better able to: Identify patients with advanced BCC who may benefit from immunotherapy; Review the clinical impact of available and emerging immunotherapies for the management of patients with advanced BCC; and Describe practical strategies to manage and monitor patients with advanced BCC on immunotherapy over both the long and short term.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in